News
In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...
As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...
UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...
1d
DPA International on MSNEMA recommends approval of additional Alzheimer's treatment
The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...
The combination of a recently approved blood test for detection of Alzheimer's disease combined with two medications that ...
Okanagan Clinical Trials is offering new opportunities for people to participate in important clinical research studies ...
Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.
A new study has explored a potential link between a particular sleep pattern and the risk of Alzheimer’s disease ...
The Alzheimer’s Foundation of America (AFA) has launched a newly redesigned website to help connect families affected by ...
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results